UCH-L1 expression of podocytes in diseased glomeruli and in vitro

被引:40
|
作者
Liu, Yuan [1 ,2 ,4 ]
Wu, Jiajing [1 ,2 ]
Wu, Huijuan [1 ,2 ]
Wang, Tianzhan [1 ,2 ]
Gan, Hualei [1 ,2 ]
Zhang, Xin [1 ,2 ]
Liu, Ye [1 ,2 ]
Li, Ruixi [3 ]
Zhao, Zhonghua [1 ,2 ]
Chen, Qi [1 ,2 ]
Guo, Muyi [1 ,2 ]
Zhang, Zhigang [1 ,2 ]
机构
[1] Fudan Univ, Dept Pathol, Shanghai Med Coll, Shanghai 200032, Peoples R China
[2] Fudan Univ, Key Lab Mol Med, Shanghai Med Coll, Minist Educ, Shanghai 200032, Peoples R China
[3] Fudan Univ, Dept Anat Histol & Embryol, Shanghai Med Coll, Shanghai 200032, Peoples R China
[4] Shanghai Univ Chinese Tradit Med, Putuo Hosp, Dept Pathol, Shanghai 200062, Peoples R China
关键词
ubiquitin C-terminal hydrolase-L1 (UCH-L1); podocyte; glomerulonephritis; immunocomplex; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CARBOXYL-TERMINAL HYDROLASE; CYCLE REGULATORY PROTEINS; CELL-CYCLE; EPITHELIAL-CELLS; LUPUS-ERYTHEMATOSUS; NEPHROTIC SYNDROME; LUNG-CANCER; UBIQUITIN; PROLIFERATION;
D O I
10.1002/path.2511
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ubiquitin C-terminal hydrolase-L1 (UCH-L1), an important member of de-ubiquitination enzyme families involved in the ubiquitin-proteasome pathway, is expressed mainly in neural and reproductive systems as well as in some tumours. Recently, expression of UCH-L1 has been discovered in parietal epithelial cells of Bowman's capsules and some tubular epithelia in the kidney. However, whether UCH-L1 is expressed in the capillary tufts of the glomeruli has not yet become clear. In this study, we used immunohistochemistry, double immunofluorescence labelling, immunoelectron microscopy in kidney biopsy tissues and western blot in cultured rat podocytes to investigate the expression of UCH-L1 and the regulation of this expression in podocytes. The results demonstrated that UCH-L1 was expressed in podocytes and its expression was significantly higher in acute proliferative glomerulonephritis (APGN), lupus nephritis (LN), membranous glomerulonephritis (MGN) and IgA nephropathy than that in focal segmental glomeruloselerosis (FSGS), minimal change disease (MCD), minor abnormality and normal kidney tissues (p < 0.05). In in vitro experiments, western blot showed that UCH-L1 expression significantly increased in the two groups of podocytes co-cultured with mesangial cells exposed to ATS 50 mu l/ml and ATS 50 mu l/ml with normal human serum 30 mu l/ml, respectively (p < 0.05), while the other groups treated with TGF beta 1 1 ng/ml, TNF alpha 10 ng/ml or IL-1 10 ng/ml had little rise of UCH-L1 expression, with no statistical significance compared with normal control (P > 0.05). Further tests indicated that the percentage of PCNA-positive podocytes in LN, APGN and IgA nephropathy was significantly higher than that in MCD, FSGS and normal control (p < 0.05). These data show for the first time that podocytes do express UCH-L1 and that its expression can be increased in these immunocomplex-mediated nephrites. The immune injury is a main cause for stimulating podocytes to express UCH-L1. The expression of UCH-L1 may be associated with the regeneration of podocytes as a repair response to immunocomplex-mediated injury. Copyright (C) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:642 / 653
页数:12
相关论文
共 50 条
  • [21] PTOV1 is associated with UCH-L1 and in response to estrogen stimuli during the mouse oocyte development
    Yao, Yu-Wei
    Shi, Yan
    Jia, Zhe-Fu
    Jiang, Ya-Hong
    Gu, Zheng
    Wang, Jian
    Aljofan, Mohamad
    Sun, Zhao-Gui
    HISTOCHEMISTRY AND CELL BIOLOGY, 2011, 136 (02) : 205 - 215
  • [22] Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways
    Bonin, M
    Poths, S
    Osaka, H
    Wang, YL
    Wada, K
    Riess, O
    MOLECULAR BRAIN RESEARCH, 2004, 126 (01): : 88 - 97
  • [23] N-Terminal Truncated UCH-L1 Prevents Parkinson's Disease Associated Damage
    Kim, Hee-Jung
    Kim, Hyun Jung
    Jeong, Jae-Eun
    Baek, Jeong Yeob
    Jeong, Jaeho
    Kim, Sun
    Kim, Young-Mee
    Kim, Youhwa
    Nam, Jin Han
    Huh, Sue Hee
    Seo, Jawon
    Jin, Byung Kwan
    Lee, Kong-Joo
    PLOS ONE, 2014, 9 (06):
  • [24] The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease
    Guglielmotto, Michela
    Monteleone, Debora
    Vasciaveo, Valeria
    Repetto, Ivan Enrico
    Manassero, Giusi
    Tabaton, Massimo
    Tamagno, Elena
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [25] Crucial roles of UCH-L1 on insulin-producing cells and carbohydrate metabolism in Drosophila melanogaster model
    Linh, Dao My
    Anh, Huynh Man
    Dan, Vo Thi Hanh
    Masamitsu, Yamaguchi
    Thao, Dang Thi Phuong
    EXPERIMENTAL CELL RESEARCH, 2022, 419 (02)
  • [26] UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice
    Hussain, Sajjad
    Bedekovics, Tibor
    Liu, Qiuying
    Hu, Wenqian
    Jeon, Haeseung
    Johnson, Sarah H.
    Vasmatzis, George
    May, Danielle G.
    Roux, Kyle J.
    Galardy, Paul J.
    BLOOD, 2018, 132 (24) : 2564 - 2574
  • [27] Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders
    Lee, Yun-Tzai C.
    Hsu, Shang-Te D.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2017, 18 (07) : 733 - 745
  • [28] Membrane-associated farnesylated UCH-L1 promotes α-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease
    Liu, Zhihua
    Meray, Robin K.
    Grammatopoulos, Tom N.
    Fredenburg, Ross A.
    Cookson, Mark R.
    Liu, Yichin
    Logan, Todd
    Lansbury, Peter T., Jr.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (12) : 4635 - 4640
  • [29] UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer
    Jin, Yiting
    Zhang, Wei
    Xu, Jiawen
    Wang, Hongying
    Zhang, Zijing
    Chu, Chengyu
    Liu, Xiuping
    Zou, Qiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 12500 - 12508
  • [30] UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease
    Ardley, HC
    Scott, GB
    Rose, SA
    Tan, NGS
    Robinson, PA
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 (02) : 379 - 391